Montana Enacts Expansive Bill Intended to Protect 340B Providers

Montana Gov. Greg Gianforte (R) signed a bill last week forbidding PBMs from reimibursing 340B covered entities and their contract pharmacies less for drugs than other pharmacies.

Montana has passed a law barring pharmacy benefit managers (PBMs) from excluding 340B contract pharmacies from participating in their networks.

SB 395, known as the Montana Pharmacy Benefit Manager Oversight Act, was signed into law last week by

Read More »

North Dakota Is the Latest State to Pass a 340B Non-Discrimination Law

The North Dakota legislature (above) passed, and Gov. Doug Burgum (R) has signed, legislation prohibiting pharmacy benefit managers from discriminating against 340B covered entities or their contract pharmacies.

North Dakota Gov. Doug Burgum (R) has signed legislation prohibiting pharmacy benefit managers (PBMs) from discriminating against 340B covered entities or their contract pharmacies.

Burgum’s approval of H.B. 1492 on April 21 made North Dakota one of six states

Read More »

340B Non-Discrimination Bills Signed in Arkansas and Indiana and Passed in Tennessee

Tennessee lawmakers this week passed a 340B non-discrimination bill, sending it to Gov. Bill Lee for his signature.

Arkansas’s and Indiana’s governors have signed bills in recent days to prevent pharmacy benefit managers (PBMs) from discriminating against 340B covered entities, and a similar bill is awaiting the Tennessee governor’s signature.

Arkansas Gov. Asa Hutchinson (R) signed his state’s

Read More »

State Attorney General Is Investigating Lilly and AstraZeneca’s 340B Pricing

Eli Lilly and AstraZeneca are the latest drug makers to disclose that they have been subpoenaed by Vermont's top law enforcement official for documents and information about their participation in 340B. | Shutterstock

Eli Lilly and AstraZeneca are the latest drug makers to disclose they have received a subpoena from the Vermont attorney general’s office related to their denials of 340B ceiling prices on drugs shipped to contract pharmacies.

Lilly and

Read More »

Arkansas Passes First-of-its-Kind Bill to Counter Pharma’s 340B Contract Pharmacy Moves

Arkansas state lawmakers this week passed what is thought to be the first bill in the nation to address drug manufacturers' denials of 340B pricing on drugs dispensed by contract pharmacies. | Jim Bowen/Flickr

The Arkansas legislature on Tuesday passed what is believed to be the first bill nationally to address pharmaceutical manufacturer denials of 340B pricing on drugs when they are dispensed by contract pharmacies.

The state Senate passed the bipartisan bill,

Read More »

Vermont AG Issues Subpoena to Novartis for 340B Documents and Information

Novartis is the second known drug manufacturer subpoenaed by the Vermont attorney general over manufacturer denials of or restrictions on 340B pricing for drugs shipped to contract pharmacies.

Vermont’s top law enforcement official has asked a second drug manufacturer—Novartis—for documents and information concerning the company’s participation in the 340B program in the state.

Tuesday in its interim financial report for the first quarter of 2021, the Swiss

Read More »

NY State 340B Providers Get More Time to Challenge Reimbursement Change

New York lawmakers and Gov. Andrew Cuomo agreed on budget legislation this week that will delay a Medicaid drug benefit transfer opposed by 340B entities for two years.

New York state lawmakers and Gov. Andrew Cuomo (D) agreed this week to postpone transferring Medicaid managed care prescription drug  benefits to Medicaid fee for service (FFS) for two years, temporarily averting a significant financial loss to 340B covered entities.

Read More »

340B Entities Keeping Watch on Bills to Create State Drug Affordability Boards

The Colorado General Assembly is one of nine state legislatures considering bills to create state drug affordability boards.

Nine states are considering legislation to create boards to review prescription drug prices and intervene to lower them if drugs become too expensive or if their prices spike. Although the bills’ implications for the 340B program have not been fully

Read More »

Utah Might Soon Outflank Express Scripts’ New 340B Requirement

Utah lawmakers have passed and sent to the governor a bill that would forbid insurers or their PBMs from forcing federally qualified health centers to include modifiers on claims identifying drugs as being 340B purchased, Medicaid claims excepted.

Pharmacy benefits manager Express Scripts’ (ESI) new pharmacy reporting requirement for reclassifying a previously submitted prescription drug claim as 340B-eligible “applies to the extent not prohibited by law,” the PBM says in an FAQ on its website.

ESI’s statement in

Read More »

State Activity to Rein in PBM Discrimination Against 340B Entities Heats Up

Tennessee is one of at least six states weighing legislation to forbid PBM discrimination against 340B covered entities.

At least six states have introduced or passed bills in recent weeks that would forbid pharmacy benefit managers from discriminating against 340B covered entities regarding reimbursements and other practices.

The bills range from 340B-specific legislation to broader bills to address

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report